Abstract
Amniotic epithelial cells (AECs), an emerging source of extrafoetal stem cells, have recently attracted attention for their great regenerative potential. Since AEC amplifications are accompanied by the loss of their native epithelial phenotype and by the progressive reduction of relevant biological properties, the issue to be addressed is the development of effective culture protocols. In this context, recently, it has been demonstrated that progesterone (P4) supplementation during ovine AEC (oAEC) expansion could prevent the undesirable epithelial-mesenchymal transition (EMT). In contrast, there is no information to date on the role of the other pregnancy steroids in culture. With this aim, the present study has been designed to clarify the impact of estradiol (E2), alone or in combination with P4 (12.5 μM and 25 μM), during oAEC amplification. Steroid supplementations were assessed by testing oAEC proliferation, stemness, EMT, and osteogenic or chondrogenic plasticity. The results indicated that EMT can be prevented exclusively in the presence of high doses of P4, while it occurred rapidly in cells exposed to E2 as denoted by protein (cytokeratin-8 and alpha-SMA) and gene expression (vimentin and snail) profiles. Moreover, steroid exposure was able to influence highly oAEC plasticity. Particularly, P4-treated cells displayed a precommitment towards osteogenic lineage, confirmed by the upregulation of OCN, RUNX2, and the greater deposition of calcium nodules. Conversely, P4 exposure inhibited oAEC chondrogenic differentiation, which was induced in E2-treated cells as confirmed by the upregulation of chondrogenesis-related genes (SOX9, ACAN, and COL2A1) and by the accumulation of Alcian blue-positive extracellular matrix. Simultaneously, E2-treated cells remained unresponsive to osteogenic inductive stimuli. In conclusion, media supplementation with high doses of steroids may be adopted to modulate phenotype and plasticity during oAEC amplification. Relevantly, the osteo or chondro steroid-induced precommitment may open unprecedented cell-based therapies to face the unsolved orthopaedic issues related to osteochondral regeneration.
Highlights
Stem cell-based regenerative medicine represents one of the most relevant challenges of the modern biomedical sciences
A validated protocol has been proposed for human amniotic-derived epithelial cells (AECs) [24] even if some evidences demonstrated that it does not guarantee the persistence of the epithelial phenotype during amplification [25,26,27,28]
The in vitro amplification of both human AEC (hAEC) and ovine AEC (oAEC) induced the spontaneous loss of the epithelial phenotype as a consequence of the epithelial-mesenchymal transition (EMT) process that occurs in culture under the influence of released paracrine/autocrine growth factors [14, 28,29,30]
Summary
Stem cell-based regenerative medicine represents one of the most relevant challenges of the modern biomedical sciences. Since the stem cell amplification represents the first critical technological step to standardize regenerative medicine protocols, before moving them towards clinical applications, the present research has been designed to assess the effects of both estradiol (E2) and P4, during the process of amplification. With this aim, high doses of steroid supplementations (12.5 μM and 25 μM), alone or in combination, were added during oAEC amplification and their impact on proliferation, stemness, phenotype, EMT, and osteogenic/chondrogenic plasticity was assessed
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.